BioStock: BrainCool’s CEO on the agreement with ZOLL

BrainCool has entered into a distribution agreement with US-based ZOLL, one of the world’s largest manufacturers and distributors of medical devices. The agreement covers the company’s IQool System for the treatment of neurological fever. BrainCool’s CEO Martin Waleij visited BioStock’s studio to talk about the deal, worth more than SEK 100 million.

Watch Martin Waleij present BrainCool and talk about the agreement with ZOLL att biostock.se:

https://www.biostock.se/en/2023/05/braincools-ceo-on-the-agreement-with-zoll/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/